With this programme, PRASHO and Pfizer aim to ensure that workplaces become safer, more informed, and more inclusive spaces ...

Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ...

Pfizer reported a 19.4% YoY rise in Q2 net profit to ₹189 crore on stronger margins and higher revenue. Shares of the company ...

India's Coronavirus Vaccine Market offers growth through government-led initiatives, robust manufacturing, and R&D in vaccine ...

Pharmaceutical giant Pfizer has finally acquired development-stage obesity drugmaker Metsera Inc., in an intense bidding war against the Danish drugmaker Novo Nordisk for over $10 billion.

Pfizer has agreed to acquire Metsera for $10 billion, outbidding Novo Nordisk in a heated competition. Metsera's board ...

Pfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer.

NEW DELHI, Dec 6 (Reuters) - Pfizer Inc (PFE.N), opens new tab has applied for emergency use authorisation of its coronavirus vaccine in India, a top government health adviser said in a TV interview ...

Pfizer will lay off 1,700 employees and cease manufacturing “immediately” at two plants in India, according to The Hindu Business Line. “Pfizer has conducted a thorough evaluation of the ...

MUMBAI (Reuters) - Pfizer Ltd(NSI:PFIZER.NS - News), the Indian unit of U.S. drug maker Pfizer Inc (NYS:PFE - News), is to take over local affiliate Wyeth Ltd (NSI:WYETH.NS - News), they said on ...

Explore the fierce competition between Novo Nordisk and Pfizer as they vie for Metsera amidst a booming obesity drug market.

Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront and a contingent value right worth up to $20.65 a ...